Melissa B. Epperly - 16 Mar 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role: Director
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Melissa B. Epperly
Issuer symbol: ROIV
Transactions as of: 16 Mar 2026
Net transactions value: -$1,200,573
Form type: 4
Filing time: 18 Mar 2026, 18:23:29 UTC
Previous filing: 22 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Epperly Melissa B,	Director	C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM	By: /s/ Jo Chen, as Attorney-in-Fact for Melissa B. Epperly	18 Mar 2026	0001807359

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ROIV	Common Shares	Sale	$1,200,573	-41,861	-73%	$28.68	15,804	16 Mar 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.50 to $28.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Content

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.50 to $28.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.